As an international medical humanitarian organisation, Médecins Sans Frontières/Doctors Without Borders (MSF) has repeatedly witnessed how the world’s most vulnerable people are left without access to the lifesaving medicines, diagnostics tests and vaccines they need. Ensuring access to these medical products requires access to information throughout their life cycle, from the R&D stages to when … Read more
“When I recover, I want to play cricket,” says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire for a brand-new bike, Deepak’s journey to pursue his goals has been long and challenging. … Read more
MSF urges public and non-profit actors to publish clinical trial costs to improve access to medical products for all. Geneva, 25 April 2024 – At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders/Médecins Sans Frontières (MSF) presented the costs of its landmark TB-PRACTECAL clinical trial that helped identify a shorter, … Read more
With routine vaccination efforts failing to reach people in fragile and emergency settings, MSF is seeing low vaccination coverage and more outbreaks of vaccine-preventable diseases, like diphtheria and measles Geneva, 15 April 2024 – Ahead of Gavi, the Vaccine Alliance’s Board Retreat on April 17-18, where the Board will shape Gavi’s strategic framework for the next … Read more
Mumbai, India- Namrata’s story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even formidable conditions like drug-resistant tuberculosis (DR-TB) can be overcome. In 2016, Namrata was employed at a daycare in an international school … Read more
Namrata’s story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even conditions like drug-resistant tuberculosis (DR-TB) can be overcome. In 2016, Namrata was employed at a daycare in an international school in Chembur, Mumbai. … Read more
Geneva/Delhi, 12 March 2024: On 10 March 2024, it was announced that India and the European Free Trade Association (EFTA) signed a free trade agreement (FTA) they have been negotiating since 2006. Full text of agreement along with Annex and the Record of Understanding has been published by EFTA. Based on MSF’s analysis, while some provisions that undermined … Read more
Geneva/New Delhi, 15 February 2024 — In a welcome move today, the Indian Commerce Ministry confirmed its rejection of Switzerland’s demand for data exclusivity for medicines in the India-EFTA trade deal, and emphasised the importance of protecting the country’s generic drug production and supply. Doctors Without Borders/Médecins Sans Frontières (MSF), Public Eye, and Delhi Network … Read more
Text leaked yesterday shows India-EFTA trade deal includes excessive intellectual property provisions that may require India to gut pro-public health national laws. Geneva/New Delhi, 14 February 2024 — Following news that India and the European Free Trade Association (EFTA) – which comprises Iceland, Liechtenstein, Norway, and Switzerland – are close to finalising a trade deal, … Read more
endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis Paris, France; November 15, 2023 – Clinical trial results presented for the first time today at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant … Read more